Stockscreener 앱 받기
16.95
0.06%
-0.16
전일 마감가:
$16.79
열려 있는:
$16.75
하루 거래량:
74,690
Relative Volume:
0.41
시가총액:
$1.12B
수익:
-
순이익/손실:
$-46.13M
주가수익비율:
-20.87
EPS:
-0.8123
순현금흐름:
$-34.10M
1주 성능:
+1.39%
1개월 성능:
+4.61%
6개월 성능:
-3.51%
1년 성능:
+134.69%
1일 변동 폭
$16.32
$17.03
1주일 범위
$16.32
$17.89
52주 변동 폭
$6.66
$25.00
펄스 바이오 Stock (PLSE) Company Profile
명칭
Pulse Biosciences Inc
전화
510-906-4600
주소
3957 POINT EDEN WAY, HAYWARD, CA
PLSE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
16.83 | 1.12B | 0 | -46.13M | -34.10M | -0.8123 |
|
ISRG
Intuitive Surgical Inc
|
566.25 | 190.61B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
94.17 | 48.17B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
177.17 | 47.86B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
247.81 | 35.48B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.57 | 16.11B | 3.90B | 392.30M | 288.10M | 1.95 |
펄스 바이오 Stock (PLSE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-07-27 | 개시 | Stephens | Overweight |
| 2021-03-11 | 개시 | Maxim Group | Buy |
| 2021-01-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-12 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | 개시 | H.C. Wainwright | Buy |
모두보기
펄스 바이오 주식(PLSE)의 최신 뉴스
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2025 Earnings Call Transcript - Insider Monkey
Pulse Biosciences Earnings Call: Progress and Challenges - TipRanks
Barclays PLC Raises Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Reports Q1 2025 Financial Results - TipRanks
Pulse Biosciences Inc (PLSE) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Wells Fargo & Company MN Purchases 2,416 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Inc (PLSE) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus
Decoding Pulse Biosciences Inc (PLSE): A Strategic SWOT Insight - GuruFocus
Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results - BioSpace
Earnings Flash (PLSE) Pulse Biosciences Q1 Loss $0.25 Vs. $0.18 Loss Year Ago - marketscreener.com
Earnings call transcript: Pulse Biosciences reports Q1 2025 loss, stock edges up - Investing.com
PULSE BIOSCIENCES, INC. SEC 10-Q Report - TradingView
Pulse Biosciences Inc Reports Q1 2025 Financial Results: GAAP Net Loss of $16.8 Million, Cash Reserves at $119.3 Million - GuruFocus
Concerns Raised Over Pulse Biosciences' (PLSE) Nano-Pulse Techno - GuruFocus
Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference - Business Wire
Pulse Biosciences (PLSE) Faces Criticism Over Technology's Past Performance | PLSE Stock News - GuruFocus
PLSE Faces Skepticism over Nano-Pulse Stimulation's Commercial V - GuruFocus
After the recent decline, Pulse Biosciences, Inc. (NASDAQ:PLSE) Top Key Executive Robert Duggan's holdings have lost 4.2% of their value - simplywall.st
Pulse Biosciences names Jon Skinner as new CFO - MSN
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting - Stock Titan
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Bought by Legal & General Group Plc - Defense World
Head to Head Survey: Pulse Biosciences (NASDAQ:PLSE) & Sight Sciences (NASDAQ:SGHT) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Purchased by Invesco Ltd. - Defense World
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 25, 2025 - BioSpace
Investor Network: Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listi - GuruFocus
Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025 - BioSpace
Geode Capital Management LLC Increases Stock Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025 | PLSE Stock News - GuruFocus
Pulse Biosciences (NASDAQ:PLSE) Is In A Strong Position To Grow Its Business - Yahoo Finance
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting - The Joplin Globe
Revolutionary Nanosecond PFA Heart Treatment Takes Center Stage at HRS 2025: J&J Partnership Revealed - Stock Titan
Trading (PLSE) With Integrated Risk Controls - news.stocktradersdaily.com
Vanguard Group Inc. Purchases 150,506 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Corebridge Financial Inc. Cuts Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
20,000 Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE) Bought by Norges Bank - Defense World
KLP Kapitalforvaltning AS Buys Shares of 2,500 Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences: Some Key Questions Remain Unanswered - Seeking Alpha
Pulse Biosciences at Needham Conference: Strategic Growth and Market Expansion - Investing.com UK
Pulse Biosciences: Interesting Product, But No Revenue Stream (NASDAQ:PLSE) - Seeking Alpha
When (PLSE) Moves Investors should Listen - news.stocktradersdaily.com
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm - ACCESS Newswire
Pulse Biosciences, Inc. Announces Closing of $30 Million Rights Offering - Business Wire
Pulse Biosciences (NASDAQ:PLSE) Upgraded to Sell at StockNews.com - Defense World
PULSE BIOSCIENCES, INC. SEC 10-K Report - TradingView
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2024 Earnings Call Transcript - MSN
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up – What’s Next? - Defense World
Pulse Biosciences Insiders Placed Bullish Bets Worth US$2.79m - simplywall.st
Pulse Biosciences Earnings Call: Progress Amid Challenges - TipRanks
Pulse Biosciences Inc Reports Q4 2024 GAAP Net Loss of $19.4 Mil - GuruFocus
펄스 바이오 (PLSE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
펄스 바이오 주식 (PLSE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| DUGGAN ROBERT W | Director |
Dec 13 '24 |
Buy |
17.18 |
55,256 |
949,298 |
42,328,717 |
| DUGGAN ROBERT W | Director |
Dec 12 '24 |
Buy |
17.13 |
45,404 |
777,771 |
42,273,461 |
| DUGGAN ROBERT W | Director |
Dec 11 '24 |
Buy |
17.35 |
56,054 |
972,344 |
42,228,057 |
| Barrett Burke Thomas | President and CEO |
May 20 '24 |
Buy |
8.56 |
10,000 |
85,600 |
10,000 |
0.29%
3.91%
자본화:
|
볼륨(24시간):